HuGE Navigator logo   HuGE Navigator (version 1.4)
   An integrated, searchable knowledge base of genetic associations and human genome epidemiology.
line
 HuGE Navigator > HuGE Literature Finder  Last data upload: 03 Feb 2010. (Total 48616 articles)  
HuGE Literature Finder
Data collected since 2001

Home  |  About  |  Search Instructions |  FAQs 

Search  
 for
Search Criteria: Meta-analysis and cancer[Text+MeSH] [Query Detail]

Filtered By  

Articles 1 - 25 of 396
Export Display on    of 16
1.
A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review. [Detail]
Medical oncology (Northwood, London, England) 2010 Jan .
Gong C, Hu X, Gao Y, Cao Y, Gao F, Mo Z
2.
Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls. [Detail]
Breast cancer research and treatment 2010 Jan .
Ma X, Qi X, Chen C, Lin H, Xiong H, Li Y, Jiang J
3.
Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis. [Detail]
Cancer genetics and cytogenetics 2010 Jan 196 (2): 2.
Yang DS, Sung HJ, Woo OH, Park KH, Woo SU, Kim AR, Lee ES, Lee JB, Kim YH, Kim JS, Seo JH
4.
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. [Detail]
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jan 19 (1): 1.
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Berchuck A, Moorman PG, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Yang HP, Garcia-Closas M, Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Ziogas A, Brewster W, Anton-Culver H, Pearce CL
5.
Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: A meta-analysis. [Detail]
Cancer epidemiology 2010 Jan .
Wan H, Zhou Y, Yang P, Chen B, Jia G, Wu X
6.
IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls. [Detail]
Breast cancer research and treatment 2010 Jan .
Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC
7.
Intron 3 16bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. [Detail]
Carcinogenesis 2010 Jan .
Hu Z, Li X, Qu X, He Y, Ring BZ, Song E, Su L
8.
Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies. [Detail]
Breast cancer research and treatment 2010 Jan .
Gu D, Wang M, Zhang Z, Chen J
9.
Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects. [Detail]
Breast cancer research and treatment 2010 Jan .
Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC
10.
Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects. [Detail]
Breast cancer research and treatment 2010 Jan .
Yao L, Yu X, Yu L
11.
No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis. [Detail]
Breast cancer research and treatment 2010 Jan .
Yu KD, Chen AX, Shao ZM
12.
No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls. [Detail]
Breast cancer research and treatment 2010 Jan .
Ma X, Chen C, Xiong H, Fan J, Li Y, Lin H, Xu R, Huang G, Xu B
13.
TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies. [Detail]
Cancer genetics and cytogenetics 2010 Jan 196 (1): 1.
Wei BB, Xi B, Wang R, Bai JM, Chang JK, Zhang YY, Yoneda R, Su JT, Hua LX
14.
The association between interleukin-10-592 polymorphism and gastric cancer risk: a meta-analysis. [Detail]
Medical oncology (Northwood, London, England) 2010 Jan .
Zhu Y, Wang J, He Q, Zhang JQ
15.
The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis. [Detail]
Breast cancer research and treatment 2010 Jan .
Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, Yu L
16.
The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. [Detail]
Breast cancer research and treatment 2010 Jan .
Yuan W, Xu L, Feng Y, Yang Y, Chen W, Wang J, Pang D, Li D
17.
Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis. [Detail]
Breast cancer research and treatment 2010 Jan .
Economopoulos KP, Sergentanis TN
18.
Tumor Necrosis Factor (TNF) and Lymphotoxin-{alpha} (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium. [Detail]
American journal of epidemiology 2010 Jan .
Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, Schenk M, Spinelli JJ, Slager SL, De Roos AJ, Smith MT, Roman E, Cozen W, Boffetta P, Kricker A, Zheng T, Lightfoot T, Cocco P, Benavente Y, Zhang Y, Hartge P, Linet MS, Becker N, Brennan P, Zhang L, Armstrong B, Smith A, Shiao R, Novak AJ, Maynadie M, Chanock SJ, Staines A, Holford TR, Holly EA, Rothman N, Wang SS
19.
XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis. [Detail]
Breast cancer research and treatment 2010 Jan .
Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC
20.
Association between CYP2E1 genetic polymorphisms and lung cancer risk: A meta-analysis. [Detail]
European journal of cancer (Oxford, England : 1990) 2009 Dec .
Wang Y, Yang H, Li L, Wang H, Zhang C, Yin G, Zhu B
21.
Association between EGF promoter polymorphisms and cancer risk: a meta-analysis. [Detail]
Medical oncology (Northwood, London, England) 2009 Dec .
Xu W, Li Y, Wang X, Chen B, Liu S, Wang Y, Zhao W, Wu J
22.
Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. [Detail]
Breast cancer research and treatment 2009 Dec .
Sergentanis TN, Economopoulos KP
23.
Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. [Detail]
GWAS Integrator
Human molecular genetics 2009 Dec 18 (23): 23.
Hazra A, Kraft P, Lazarus R, Chen C, Chanock SJ, Jacques P, Selhub J, Hunter DJ
24.
Review of studies on metabolic genes and cancer in populations of African descent. [Detail]
Genetics in medicine : official journal of the American College of Medical Genetics 2009 Dec .
Ragin CC, Langevin S, Rubin S, Taioli E
25.
TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. [Detail]
Breast cancer research and treatment 2009 Dec .
Fang F, Yao L, Yu XJ, Yu L, Wu Q, Yu L
Export Display 25 on page   1 of  16
Articles 1 - 25 of 396